Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
J Biotechnol ; 191: 131-8, 2014 Dec 10.
Artigo em Inglês | MEDLINE | ID: mdl-25450637

RESUMO

Pseudomonas aeruginosa is a leading cause of hospital-acquired infections in patients with compromised host defense mechanisms, including burn wound victims. In addition to its intrinsic resistance against most antibiotics, P. aeruginosa has the ability to form biofilms adhering to biotic or abiotic surfaces. These factors make treatment of P. aeruginosa infections complicated and demand new therapies and drugs. The flagellum of P. aeruginosa plays an important role in cell­cell and cell­surface interactions during the first stage of biofilm formation. In this study, we describe the selection of monoclonal anti-flagellin single-domain antibodies (VHHs) derived from the Camelid heavy-chain antibody repertoire of a llama immunized with P. aeruginosa antigens. The anti-flagellin VHHs could be produced efficiently in Saccharomyces cerevisiae, and surface plasmon resonance experiments demonstrated that they have apparent affinities in the nanomolar range. Functional screens showed that the anti-flagellin VHHs are capable of inhibiting P. aeruginosa from swimming and that they prevent biofilm formation in an in vitro assay. These data open doors for the development of novel methods for the prevention of P. aeruginosa-related infections.


Assuntos
Biofilmes/efeitos dos fármacos , Infecções por Pseudomonas/tratamento farmacológico , Pseudomonas aeruginosa/efeitos dos fármacos , Anticorpos de Domínio Único/administração & dosagem , Animais , Antibacterianos/uso terapêutico , Camelídeos Americanos , Flagelos/imunologia , Flagelina/antagonistas & inibidores , Flagelina/imunologia , Humanos , Pseudomonas aeruginosa/imunologia , Pseudomonas aeruginosa/patogenicidade , Saccharomyces cerevisiae , Anticorpos de Domínio Único/imunologia
2.
J Biotechnol ; 186: 66-73, 2014 Sep 30.
Artigo em Inglês | MEDLINE | ID: mdl-24997356

RESUMO

Pseudomonas aeruginosa is a leading cause of hospital-acquired infections in patients with compromised host defense mechanisms, including burn wound victims. In addition to its intrinsic resistance against most antibiotics, P. aeruginosa has the ability to form biofilms adhering to biotic or abiotic surfaces. These factors make treatment of P. aeruginosa infections complicated and demand new therapies and drugs. The flagellum of P. aeruginosa plays an important role in cell-cell and cell-surface interactions during the first stage of biofilm formation. In this study, we describe the selection of monoclonal anti-flagellin single-domain antibodies (VHHs) derived from the Camelid heavy-chain antibody repertoire of a llama immunized with P. aeruginosa antigens. The anti-flagellin VHHs could be produced efficiently in Saccharomyces cerevisiae, and surface plasmon resonance experiments demonstrated that they have apparent affinities in the nanomolar range. Functional screens showed that the anti-flagellin VHHs are capable of inhibiting P. aeruginosa from swimming and that they prevent biofilm formation in an in vitro assay. These data open doors for the development of novel methods for the prevention of P. aeruginosa-related infections.


Assuntos
Antibacterianos , Biofilmes/efeitos dos fármacos , Flagelos/metabolismo , Pseudomonas aeruginosa/efeitos dos fármacos , Anticorpos de Domínio Único , Sequência de Aminoácidos , Animais , Antibacterianos/química , Antibacterianos/metabolismo , Antibacterianos/farmacologia , Camelídeos Americanos , Flagelos/efeitos dos fármacos , Flagelos/imunologia , Flagelina/imunologia , Flagelina/metabolismo , Dados de Sequência Molecular , Alinhamento de Sequência , Anticorpos de Domínio Único/química , Anticorpos de Domínio Único/metabolismo , Anticorpos de Domínio Único/farmacologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...